Berlin’s recreational cannabis trial halted by federal regulators
A plan to test the sale of recreational cannabis in Berlin has been blocked by federal authorities. The Federal Office for Agriculture and Food (BLE) rejected an application from three district offices, arguing that such trials need separate national laws. The decision has sparked criticism from local officials who insist their project complies with existing rules.
The pilot project was developed by the district offices of Friedrichshain-Kreuzberg, Neukölln, and Pankow, in partnership with Humboldt University. It aimed to allow controlled cannabis sales in licensed shops, with the Sanity Group GmbH set to manage implementation. However, the BLE ruled that the Cannabis Consumption Act (KCanG) does not cover regional or time-limited trials, requiring new federal legislation instead.
The rejection leaves the Berlin districts without approval to proceed. The applicants maintain their legal position but must now decide whether to appeal or adjust their plans. Meanwhile, the BLE continues to review remaining applications under the current regulatory framework.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
